Skip to main content

Generics

  • Par Pharmaceutical to distribute authorized generic of Covis's Lanoxin (digoxin) tablets

    WOODCLIFF LAKE, N.J. — Par Pharmaceutical on Thursday announced that it has entered into an exclusive U.S. supply and distribution agreement with Covis Pharma S.a.r.l. to distribute the authorized generic version of Covis's Lanoxin (digoxin) tablets. 

    According to IMS Health data, annual U.S. sales of digoxin tablets are approximately $44 million. 

  • NCPA places support behind Diabetic Testing Supply Access Act

    ALEXANDRIA, Va. — The National Community Pharmacists Association on Thursday expressed its support behind the Diabetic Testing Supply Access Act (S. 1935). 

    The legislation would allow independent community pharmacies to provide same-day delivery of diabetes testing supplies to Medicare beneficiaries and was introduced by Senss Jerry Moran, R-Kan., and John Thune, R-S.D. 

    Since July 1, 2013 community pharmacies have been banned from delivering DTS to beneficiaries, including those who are homebound or in long-term care or assisted living facilities. 

  • National Consumers League survey finds 1-in-5 adults never received a flu shot

    WASHINGTON — A survey released by the National Consumers League found that more than 1-in-5 (22%) U.S. parents surveyed admitted they’ve never received a flu shot, and only half (53%) of parents with children ages 17 years and younger have received a flu vaccination within the last year. 

  • Analysis: Only 1-in-3 adults ages 18 to 64 years get the flu shot

    WASHINGTON — An analysis released Tuesday by the Trust for America's Health found that only 35.7% of adults ages 18 to 64 years got the flu shot last season. By comparison, 56.6% of children ages 6 months to 17 years old and 66.2% of seniors were vaccinated.  

    "The trend of low vaccination rates among younger adults is particularly troubling this year, when they are more at risk than usual for the effects of the H1N1 strain of flu that's circulating," stated Jeffrey Levi, executive director of TFAH.

  • House restores $85 million in FDA sequestered user fees

    WASHINGTON — The U.S. House of Representatives on Wednesday voted to restore $85 million in Food and Drug Administration sequestered user fees.

  • Perrigo launches generic equivalent to prescription-only Vanos Cream 0.1%

    DUBLIN — Perrigo on Tuesday announced that it has received final approval for its abbreviated new drug application for fluocinonide cream 0.1%, the generic equivalent to prescription-only Vanos Cream 0.1%. 

    Perrigo was awarded 180-days of generic drug exclusivity as it was the first company to submit an ANDA containing a paragraph IV certification. Perrigo had previously resolved litigation with the brand and has commenced shipment of the product.

  • FDA recommends health professionals prescribe no more than 325 mg of acetaminophen per dose

    SILVER SPRING, Md. — The Food and Drug Administration on Tuesday recommended healthcare professionals discontinue prescribing and dispensing prescription combination drug products that contain more than 325 mg of acetaminophen per tablet, capsule or other dosage unit. 

  • Cardinal Health Foundation releases video game to raise awareness around prescription drug abuse

    DUBLIN, Ohio — In its newest educational program, the Generation Rx Initiative mixes online learning with video games released Wednesday to promote learning about the dangers of prescription drug misuse and abuse. The game can be integrated into parents' and teachers' National Drug Facts Week efforts Jan. 27 to Feb. 2. NDFW is a health observance week for teens that aims to shatter the myths about drugs and drug abuse through community-based events and educational activities on the Web, on television and through contests.

X
This ad will auto-close in 10 seconds